Hadassah and Bar-Ilan University launch Phase I trial to treat incurable multiple myeloma. A team of Israeli scientists and doctors have developed the country’s first blue-and-white CAR T immunotherapy for the treatment of multiple myeloma, potentially giving thousands of sick patients access to this lifesaving treatment. Read More.
